CRISPR Cell Lines: A Guide to Gene Editing and Applications
CRISPR/Cas9 is a gene-editing system derived from bacterial immunity, enabling precise genome cleavage in eukaryotic cells. It consists of sgRNA, which targets specific DNA sequences via base pairing, and the Cas9 nuclease, which cuts DNA near a PAM site.
Cells repair Cas9-induced double-strand breaks via two pathways: error-prone non-homologous end joining (NHEJ), often causing indels for gene knockout, and homology-directed repair (HDR), allowing precise gene insertion with a donor template.
Key Applications
(i) Generating knockout cell lines by targeting exons with gRNAs to induce frameshift mutations via NHEJ.
(ii) Performing gene knock-in via HDR for precise integration.
(iii) Modeling diseases, such as mimicking leukemia-associated translocations in hematopoietic cells.
Technical Improvements
(i) Engineering enhanced Cas9 variants with improved activity and PAM recognition.
(ii) Optimizing delivery methods (viral/non-viral).
(iii) Reducing off-target effects using high-fidelity Cas9 and optimized gRNAs.
Research Areas
(i) Gene function and pathway studies.
(ii) Developing genetic disease models.
(iii) Engineering cell lines for therapeutic protein production.
Alpha Lifetech provides comprehensive technical support and end-to-end solutions for Stable Cell Line Construction. Our services utilize a variety of methods, including gene editing, to meet diverse research needs.